These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 16198621)
41. Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet. Machado MV; Ravasco P; Jesus L; Marques-Vidal P; Oliveira CR; Proença T; Baldeiras I; Camilo ME; Cortez-Pinto H Scand J Gastroenterol; 2008 Jan; 43(1):95-102. PubMed ID: 18938777 [TBL] [Abstract][Full Text] [Related]
42. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress. Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305 [TBL] [Abstract][Full Text] [Related]
43. Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice. Kato J; Koda M; Kishina M; Tokunaga S; Matono T; Sugihara T; Ueki M; Murawaki Y Int J Mol Med; 2012 Jul; 30(1):107-13. PubMed ID: 22469867 [TBL] [Abstract][Full Text] [Related]
44. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Ito S; Yukawa T; Uetake S; Yamauchi M Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172 [TBL] [Abstract][Full Text] [Related]
45. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease. Farrell GC; Haczeyni F; Chitturi S Adv Exp Med Biol; 2018; 1061():19-44. PubMed ID: 29956204 [TBL] [Abstract][Full Text] [Related]
46. Pathogenesis of non-alcoholic fatty liver disease mediated by YAP. Chen P; Luo Q; Huang C; Gao Q; Li L; Chen J; Chen B; Liu W; Zeng W; Chen Z Hepatol Int; 2018 Jan; 12(1):26-36. PubMed ID: 29330836 [TBL] [Abstract][Full Text] [Related]
47. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction. Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129 [TBL] [Abstract][Full Text] [Related]
48. Soybean Oil-Derived Poly-Unsaturated Fatty Acids Enhance Liver Damage in NAFLD Induced by Dietary Cholesterol. Henkel J; Alfine E; Saín J; Jöhrens K; Weber D; Castro JP; König J; Stuhlmann C; Vahrenbrink M; Jonas W; Kleinridders A; Püschel GP Nutrients; 2018 Sep; 10(9):. PubMed ID: 30231595 [TBL] [Abstract][Full Text] [Related]
58. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. Farzanegi P; Dana A; Ebrahimpoor Z; Asadi M; Azarbayjani MA Eur J Sport Sci; 2019 Aug; 19(7):994-1003. PubMed ID: 30732555 [TBL] [Abstract][Full Text] [Related]
59. Role of Oxidative Stress and Lipid Peroxidation in the Pathophysiology of NAFLD. Martín-Fernández M; Arroyo V; Carnicero C; Sigüenza R; Busta R; Mora N; Antolín B; Tamayo E; Aspichueta P; Carnicero-Frutos I; Gonzalo-Benito H; Aller R Antioxidants (Basel); 2022 Nov; 11(11):. PubMed ID: 36358589 [TBL] [Abstract][Full Text] [Related]
60. Cooperation of liver cells in health and disease. Kmieć Z Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]